EL CAJON, Calif.–( SERVICE CABLE)– #Antimicrobial– PURE Bioscience, Inc. (OTCQB: PURE) (” PURE,” the “Business” or “we”), designer of the trademarked safe silver dihydrogen citrate (SDC) antimicrobial, today reported monetary outcomes for the monetary very first quarter finished October 31, 2024. Recap of Outcomes– Financial Very First Quarter Procedures Internet item sales were $555,000 and $718,000 for the monetary very first quarters finished October 31, 2024 and 2023, specifically. The decline of $163,000 was attributable to budgetar
发布者：Dr.Durant，转转请注明出处：https://robotalks.cn/pure-bioscience-reports-fiscal-first-quarter-2025-financial-results/
